25 September 2018: The global cardiac
marker testing market is portraying exponential growth at a high CAGR
in forthcoming period due to growing incidence of cardiovascular diseases. Research
on cardiac biomarkers and rising prevalence and incidence of cardiac disease
are the major factors driving growth in cardiac marker testing markets. Cardiac
Bio-marker diagnostic test market is used to determine the concentration of
proteins also used in measuring occurrence and phase of cardiovascular disease
(CVD).
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/cardiac-marker-testing-market
Growing
prevalence of cardiovascular diseases, rapidly growing geriatric population and
growing funds from private-public funded organizations to conduct ongoing
trials are fueling the growth of cardiac markers testing market. The major
causes of CVD are smoking, high Blood Pressure, diabetes, sedentary lifestyle,
unhealthy diet, high cholesterol and obesity. However, factors such as
technical problems related to collection of samples and storage and issues in
relation to regulatory and reimbursement systems are key factors hindering
growth of the market.
Developing
countries such as India and China have proved to be popular for companies
developing cardiac biomarkers. Prevalence of cardiovascular diseases are
significant in driving growth of cardiac biomarker testing market. China is top
nation in CVD mortality rates and of importance here is that biomarkers help in
early diagnosis of disease and hence help doctors and clinicians around the
world with technological advances among doctors and clinicians talked in
seminars are propelling demand for cardiac biomarkers in emerging markets.
Market Segment:
Geographically, this report is segmented
into several key Regions, with production, consumption, revenue (million USD),
market share and growth rate of Cardiac Marker Testing in these regions, from
2013 to 2025 (forecast), covering
•
North America
•
Europe
•
China
•
Japan
•
Southeast Asia
•
India
Global Cardiac Marker Testing market
competition by top manufacturers, with production, price, revenue (value) and
market share for each manufacturer; the top players including
•
Roche Diagnostics
•
Abbott Laboratories
•
Siemens
•
Danaher Corporation
•
Alere Inc
•
BioMerieux
•
LSI Medience Corporation
•
Ortho Clinical Diagnostics
•
Randox Laboratories Ltd
•
Guangzhou Wondfo Biotech
On the basis of product, this report
displays the production, revenue, price, market share and growth rate of each
type, primarily split into
•
Chemiluminescence
•
Immunofluorescence
•
ELISA
•
Immunochromatography
On the basis of the end
users/applications, this report focuses on the status and outlook for major applications/end
users, consumption (sales), market share and growth rate for each application,
including
•
Pharmaceutical Companies
•
Reagents Manufacturers
•
Imaging Instrument Providers
Table of Contents
1
Cardiac Marker Testing Market Overview
2
Global Cardiac Marker Testing Market Competition by Manufacturers
3
Global Cardiac Marker Testing Capacity, Production, Revenue (Value) by Region
(2013-2018)
4
Global Cardiac Marker Testing Supply (Production), Consumption, Export, Import
by Region (2013-2018)
5
Global Cardiac Marker Testing Production, Revenue (Value), Price Trend by Type
6
Global Cardiac Marker Testing Market Analysis by Application
7
Global Cardiac Marker Testing Manufacturers Profiles/Analysis
8
Cardiac Marker Testing Manufacturing Cost Analysis
9
Global Cardiac Marker Testing Market Forecast (2018-2025)
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/cardiac-marker-testing-market/request-sample
No comments:
Post a Comment